258 related articles for article (PubMed ID: 21460853)
1. ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability.
Goetz EM; Shankar B; Zou Y; Morales JC; Luo X; Araki S; Bachoo R; Mayo LD; Boothman DA
Oncogene; 2011 Sep; 30(35):3745-54. PubMed ID: 21460853
[TBL] [Abstract][Full Text] [Related]
2. ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence.
Luo X; Suzuki M; Ghandhi SA; Amundson SA; Boothman DA
PLoS One; 2014; 9(6):e99983. PubMed ID: 24937130
[TBL] [Abstract][Full Text] [Related]
3. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
[TBL] [Abstract][Full Text] [Related]
4. Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
Klokov D; Leskov K; Araki S; Zou Y; Goetz EM; Luo X; Willson D; Boothman DA
Oncogene; 2013 Jan; 32(4):479-90. PubMed ID: 22391565
[TBL] [Abstract][Full Text] [Related]
5. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.
Shahrabani-Gargir L; Pandita TK; Werner H
Endocrinology; 2004 Dec; 145(12):5679-87. PubMed ID: 15345673
[TBL] [Abstract][Full Text] [Related]
6. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
7. Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.
Chesnokova V; Zonis S; Wawrowsky K; Tani Y; Ben-Shlomo A; Ljubimov V; Mamelak A; Bannykh S; Melmed S
Mol Endocrinol; 2012 Dec; 26(12):2092-103. PubMed ID: 23051594
[TBL] [Abstract][Full Text] [Related]
8. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
9. BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.
Fabbro M; Savage K; Hobson K; Deans AJ; Powell SN; McArthur GA; Khanna KK
J Biol Chem; 2004 Jul; 279(30):31251-8. PubMed ID: 15159397
[TBL] [Abstract][Full Text] [Related]
10. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
[TBL] [Abstract][Full Text] [Related]
11. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.
Ching JK; Luebbert SH; Collins RL; Zhang Z; Marupudi N; Banerjee S; Hurd RD; Ralston L; Fisher JS
Exp Physiol; 2013 Feb; 98(2):526-35. PubMed ID: 22941977
[TBL] [Abstract][Full Text] [Related]
12. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
[TBL] [Abstract][Full Text] [Related]
13. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
[TBL] [Abstract][Full Text] [Related]
14. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage.
Yang Y; Xia F; Hermance N; Mabb A; Simonson S; Morrissey S; Gandhi P; Munson M; Miyamoto S; Kelliher MA
Mol Cell Biol; 2011 Jul; 31(14):2774-86. PubMed ID: 21606198
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells.
Knobel PA; Kotov IN; Felley-Bosco E; Stahel RA; Marti TM
Neoplasia; 2011 Oct; 13(10):961-70. PubMed ID: 22028621
[TBL] [Abstract][Full Text] [Related]
16. ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage.
Moumen A; Magill C; Dry KL; Jackson SP
Cell Cycle; 2013 Feb; 12(4):698-704. PubMed ID: 23343766
[TBL] [Abstract][Full Text] [Related]
17. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
18. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling.
Yamauchi M; Oka Y; Yamamoto M; Niimura K; Uchida M; Kodama S; Watanabe M; Sekine I; Yamashita S; Suzuki K
DNA Repair (Amst); 2008 Mar; 7(3):405-17. PubMed ID: 18248856
[TBL] [Abstract][Full Text] [Related]
19. The HINT1 tumor suppressor regulates both gamma-H2AX and ATM in response to DNA damage.
Li H; Balajee AS; Su T; Cen B; Hei TK; Weinstein IB
J Cell Biol; 2008 Oct; 183(2):253-65. PubMed ID: 18852295
[TBL] [Abstract][Full Text] [Related]
20. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage.
Vadnais C; Davoudi S; Afshin M; Harada R; Dudley R; Clermont PL; Drobetsky E; Nepveu A
Nucleic Acids Res; 2012 May; 40(10):4483-95. PubMed ID: 22319212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
